🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to investigate the SP2086 pharmacokinetic in Re...
Status
Completed
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT02815774
Treatments Being Tested
SP2086 is a novel inhibitor of Dipeptide base peptidase 4, allows an insuli...
Status
Unknown
Location
the First Hosital of Jilin University
Start Date
2016-04
Trial ID
NCT02822534
Treatments Being Tested
SP2086 is a new dipeptidyl peptidase(DPP)-4 inhibitor. This study aims to e...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2012-03
Trial ID
NCT01969318
Treatments Being Tested
This study used a single-dose, open design to compare the pharmacokinetics ...
Status
Unknown
Location
Multiple Locations
Start Date
2023-09
Trial ID
NCT06035406
Treatments Being Tested
The purpose of the study is to investigate the potential PK interaction bet...
Status
Unknown
Location
People's Liberation Army General Hospital of Chengdu Military Region
Start Date
2016-03
Trial ID
NCT02817217
SP2086 is a novel inhibitor of Dipeptide base peptidase 4, allows an insuli...
Status
Unknown
Location
the First Hosital of Jilin University
Start Date
2016-07
Trial ID
NCT02826044
Treatments Being Tested
The purpose of the study is to investigate the Metabolite identification an...
Status
Completed
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02815748
Treatments Being Tested
All eligible subjects were randomly assigned to group A and group B sequenc...
Status
Unknown
Location
The First Hospital of Jilin University
Start Date
2016-03
Trial ID
NCT02821871
Treatments Being Tested
This is an open single and self-control study,planning to recruit 24 cases ...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02813863
SP2086 is a new dipeptidy1 peptidase(DPP)-4 inhibitors. This study aims to ...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2011-06
Trial ID
NCT01969357
Treatments Being Tested